Healthcare Realty Trust vs Omega Healthcare Investors
HR and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HR and OHI compare
Omega Healthcare Investors is the larger company, worth 2.3 times as much as Healthcare Realty Trust ($14.2B against $6.2B).
Omega Healthcare Investors grew revenue faster over the last twelve months (15.0% versus −5.8% for Healthcare Realty Trust).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with −4.0% at Healthcare Realty Trust.
Both pay dividends: Healthcare Realty Trust yields 5.3% and Omega Healthcare Investors 5.7%.
Omega Healthcare Investors scores higher on the StockData Score (12 against 5 for Healthcare Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HR | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $6.2B | $14.2B |
| Share price | $18.13 | $46.98 |
| Change, 1 year | 1.1% | 18.8% |
| Change, 5 years | −44.6% | 57.0% |
| Beta (5Y) | 0.53 | 0.27 |
| Employees | 539 | 69 |
| StockData Score | ||
| Total score | 5 | 12 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 0 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | – | 17.0× |
| P/S | 5.5× (better) | 11.1× |
| P/B | 1.5× (better) | 2.6× |
| EV/EBITDA | – | 10.0× |
| PEG | – | 6.71 |
| Fair value | $16.35 | $52.14 |
| Margin of safety | −10.9% | 9.9% (better) |
| Growth | ||
| Revenue growth (TTM) | −5.8% | 15.0% (better) |
| Revenue growth, 5Y average | 18.8% (better) | 5.9% |
| Net income growth (TTM) | – | 82.4% |
| EPS growth (TTM) | – | 73.1% |
| EPS growth, 5Y average | – | 22.6% |
| Profitability | ||
| Net margin | −4.0% | 67.0% (better) |
| Return on equity | −1.0% | 16.5% (better) |
| Financial health | ||
| Altman Z-score | 0.90 | 2.81 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 5.3% | 5.7% (better) |
| Payout ratio | – | 92.6% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −1.7% | 0.00% (better) |
| Buyback yield | 0.05% | – |
| Shareholder yield | 5.3% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 110% | 81.8% |
| Held by insiders | 4.9% | 0.19% |
| Insider net buying, 12 months | −$745K | $1.4M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.8% | 5.2% |
Go deeper
- HR stock overview
- HR income statement
- HR valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.